Your browser doesn't support javascript.
Diagnostic Process in Rare Diseases: Determinants Associated with Diagnostic Delay.
Benito-Lozano, Juan; Arias-Merino, Greta; Gómez-Martínez, Mario; Ancochea-Díaz, Alba; Aparicio-García, Aitor; Posada de la Paz, Manuel; Alonso-Ferreira, Verónica.
  • Benito-Lozano J; Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Arias-Merino G; Universidad Nacional de Educación a Distancia (UNED), 28015 Madrid, Spain.
  • Gómez-Martínez M; Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Ancochea-Díaz A; Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Aparicio-García A; Spanish Federation of Rare Diseases (FEDER), 28009 Madrid, Spain.
  • Posada de la Paz M; The State Reference Center for Assistance to People Living with Rare Diseases and Their Families (CREER), Centro de Referencia Estatal de Atención a Personas con Enfermedades Raras y sus Familias, Dependiente del IMSERSO, 09001 Burgos, Spain.
  • Alonso-Ferreira V; Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Int J Environ Res Public Health ; 19(11)2022 05 26.
Article in English | MEDLINE | ID: covidwho-1892851
ABSTRACT
Many people living with rare disease (RD) report a difficult diagnostic process from the symptom onset until they obtain the definitive diagnosis. The aim of this study was thus to ascertain the diagnostic process in RDs, and explore the determinants related with having to wait for more than one year in this process (defined as "diagnostic delay"). We conducted a case-control study, using a purpose-designed form from the Spanish Rare Diseases Patient Registry for data-collection purposes. A descriptive analysis was performed and multivariate backward logistic regression models fitted. Based on data on 1216 patients living with RDs, we identified a series of determinants associated with experiencing diagnostic delay. These included having to travel to see a specialist other than that usually consulted in the patient's home province (OR 2.1; 95%CI 1.6-2.9); visiting more than 10 specialists (OR 2.6; 95%CI 1.7-4.0); being diagnosed in a region other than that of the patient's residence at the date of symptom onset (OR 2.3; 95%CI 1.5-3.6); suffering from a RD of the nervous system (OR 1.4; 95%CI 1.0-1.8). In terms of time taken to see a specialist, waiting more than 6 months to be referred from the first medical visit was the period of time which most contributed to diagnostic delay (PAR 30.2%). In conclusion, this is the first paper to use a collaborative study based on a nationwide registry to address the diagnostic process of patients living with RDs. While the evidence shows that the diagnostic process experienced by these persons is complex, more studies are needed to determine the implications that this has for their lives and those of their families at a social, educational, occupational, psychological, and financial level.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rare Diseases / Delayed Diagnosis Type of study: Diagnostic study / Observational study Topics: Long Covid Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Ijerph19116456

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Rare Diseases / Delayed Diagnosis Type of study: Diagnostic study / Observational study Topics: Long Covid Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Ijerph19116456